Three-Year Efficacy and Safety of Erenumab in Participants with Episodic Migraine and 2-4 Prior Preventive Treatment Failures: Results from the LIBERTY Study

被引：0

作者：

Reuter, Uwe ^{[1
,2
]}

Goadsby, Peter ^{[3
,4
]}

Ferrari, Michel ^{[5
]}

Lima, Gabriel Paiva da Silva ^{[6
]}

Mondal, Subhayan ^{[7
]}

Wen, Shihua ^{[8
]}

Stites, Tracy ^{[8
]}

Arkuszewski, Michal ^{[9
]}

Lanteri-Minet, Michel ^{[10
,11
,12
]}

Pandhi, Shaloo ^{[9
]}

机构：

[1] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany

[2] Univ Med Greifswald, Greifswald, Germany

[3] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA

[4] Kings Coll London, Kings Clin Res Facil, NIHR Wellcome Trust, London, England

[5] Leiden Univ, Dept Neurol, Med Ctr, Leiden, Netherlands

[6] Amgen Inc, Thousand Oaks, CA 91320 USA

[7] Novartis Healthcare Pvt Ltd, Bengaluru, India

[8] Novartis Pharmaceut, Bengaluru, India

[9] Novartis Pharma AG, Bengaluru, India

[10] Univ Cote dAzur, Pain Dept, Paris, France

[11] Univ Cote dAzur, FHU InovPain, Paris, France

[12] Auvergne Univ, INSERM, Migraine & Trigeminal Pain, U1107, Paris, France

来源：

NEUROLOGY | 2022年 / 98卷 / 18期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页数：4

共 50 条

[1] Three-year efficacy and safety of erenumab in participants with episodic migraine and 2-4 prior preventive treatment failures: Results from the LIBERTY study
Reuter, U.
Goadsby, P. J.
Ferrari, M.
Lima, G. Paiva Da Silva
Mondal, S.
Wen, S.
Stites, T.
Arkuszewski, M.
Lanter-Minet, M.
Pandhi, S.
JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 2):
[2] Three-year efficacy and safety of erenumab in participants with episodic migraine and 2-4 prior preventive treatment failures: Results from the LIBERTY study
Reuter, U.
Goadsby, P. J.
Ferrari, M.
Lima, G. Paiva da Silva
Mondal, S.
Wen, S.
Stites, T.
Arkuszewski, M.
Lanter-Minet, M.
Pandhi, S.
CEPHALALGIA, 2021, 41 (1_SUPPL) : 268 - 268
[3] Two-year efficacy and safety of erenumab in participants with episodic migraine and 2-4 prior preventive treatment failures: results from the LIBERTY study
Ferrari, Michel Dominique
Reuter, Uwe
Goadsby, Peter J.
Lima, Gabriel Paiva da Silva
Mondal, Subhayan
Wen, Shihua
Tenenbaum, Nadia
Pandhi, Shaloo
Lanteri-Minet, Michel
Stites, Tracy
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2021,
[4] Two-year efficacy and safety of erenumab in participants with episodic migraine and 2-4 prior preventive treatment failures: results from the LIBERTY study
Ferrari, Michel Dominique
Reuter, Uwe
Goadsby, Peter J.
Lima, Gabriel Paiva da Silva
Mondal, Subhayan
Wen, Shihua
Tenenbaum, Nadia
Pandhi, Shaloo
Lanteri-Minet, Michel
Stites, Tracy
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (03): : 254 - 262
[5] Efficacy and safety of erenumab in episodic migraine patients with 2-4 prior preventive treatment failures: Results from the Phase 3b LIBERTY study
Reuter, Uwe
Goadsby, Peter J.
Lanteri-Minet, Michel
Ferrari, Michel
Wen, Shihua
Klatt, Jan
JOURNAL OF HEADACHE AND PAIN, 2018, 19
[6] Efficacy and Safety of Erenumab in Episodic Migraine Patients with 2-4 Prior Preventive Treatment Failures: Results from the Phase 3b LIBERTY Study
Goadsby, P. J.
Lanteri-Minet, M.
Ferrari, M.
Wen, S.
Klatt, J.
HEADACHE, 2018, 58 : 77 - 77
[7] EFFICACY AND SAFETY OF ERENUMAB IN EPISODIC MIGRAINE PATIENTS WITH 2-4 PRIOR PREVENTIVE TREATMENT FAILURES: RESULTS FROM THE PHASE 3B LIBERTY STUDY
Reuter, U.
Goadsby, P. J.
Lanteri-Minet, M.
Ferrari, M. D.
Wen, S.
Hours-Zesiger, P.
Klatt, J.
CEPHALALGIA, 2018, 38 : 60 - 60
[8] EFFECT OF ERENUMAB ON PATIENT-REPORTED OUTCOMES IN PATIENTS WITH EPISODIC MIGRAINE WITH 2-4 PRIOR PREVENTIVE TREATMENT FAILURES: RESULTS FROM THE LIBERTY STUDY
Goadsby, P. J.
Reuter, U.
Ferrari, M. D.
Lanteri-Minet, M.
Zesiger, P. H.
Wen, S.
Klatt, J.
CEPHALALGIA, 2018, 38 : 60 - 62
[9] Efficacy and Safety of Erenumab in Participants With Episodic Migraine in Whom 2-4 Prior Preventive Treatments Had Failed
Reuter, Uwe
Goadsby, Peter J.
Ferrari, Michel D.
Da Silva Lima, Gabriel Paiva
Mondal, Subhayan
Kalim, Jawed
Hasan, Fatima
Wen, Shihua
Arkuszewski, Michal
Pandhi, Shaloo
Stites, Tracy
Lanteri-Minet, Michel
NEUROLOGY, 2024, 102 (10)
[10] SUSTAINED EFFICACY AND SAFETY OF ERENUMAB IN EPISODIC MIGRAINE PATIENTS FAILING 2-4 PRIOR PREVENTIVE TREATMENTS: 2-YEAR INTERIM RESULTS OF THE LIBERTY OPEN-LABEL EXTENSION STUDY
Reuter, Uwe
Goadsby, Peter J.
Lanteri-Minet, Michel
Stites, Tracy
Wen, Shihua
Tenenbaum, Nadia
Ferrari, Michel D.
Pandhi, Shaloo
CEPHALALGIA, 2020, 40 : 58 - 59

← 1 2 3 4 5 →